Relief Therapeutics Holding SA RLF-CH:Swiss Exchange

*Data is delayed | Exchange | CHF
Last | 10:27 AM CEST
1.33quote price arrow down-0.01 (-0.75%)
Volume
2,019
52 week range
1.20 - 15.00
Loading...
  • Open1.34
  • Day High1.34
  • Day Low1.23
  • Prev Close1.34
  • 52 Week High15.00
  • 52 Week High Date05/05/23
  • 52 Week Low1.20
  • 52 Week Low Date04/19/24

Key Stats

  • Market Cap17.55M
  • Shares Out12.22M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta0.81
  • YTD % Change-

KEY STATS

  • Open1.34
  • Day High1.34
  • Day Low1.23
  • Prev Close1.34
  • 52 Week High15.00
  • 52 Week High Date05/05/23
  • 52 Week Low1.20
  • 52 Week Low Date04/19/24
  • Market Cap17.55M
  • Shares Out12.22M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta0.81
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-7.36
  • P/E (TTM)-0.18
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Relief Therapeutics Holding SA

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
RELIEF THERAPEUTICS Holding SA is a Switzerland-based biopharmaceutical company. The Company’s objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need, as well as to focus on developing treatments for respiratory diseases. It specializes in clinical-stage projects based on molecules of natural origin (peptides and proteins with a history of clinical use and either initial human activity with efficacy data or a strong...
Raghuram Selvaraju Ph.D.
Chairman of the Board
Michelle Lock
Interim Chief Executive Officer, Director
Paolo Galfetti
Chief Operating Officer, Director
Jeremy Meinen
Chief Financial Officer, Treasurer
Address
Avenue de Secheron 15
Geneve
1202
Switzerland